Gabriela Schmajuk1, Bimba F Hoyer2, Martin Aringer3, Sindhu R Johnson4, David I Daikh1, Thomas Dörner2. 1. University of California, San Francisco, and the Department of Veterans Affairs Medical Center, San Francisco. 2. Charité University Hospital and Deutschen Rheuma-Forschungszentrums, Berlin, Germany. 3. University Medical Center Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. 4. Toronto Western Hospital, University Health Network, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada.
Abstract
OBJECTIVE: The American College of Rheumatology and the European League Against Rheumatism embarked on a project to reevaluate classification criteria for systemic lupus erythematosus (SLE). The first phase of the classification project involved generation of a broad set of items potentially useful for classification of SLE and their selection for use in a subsequent forced-choice decision analysis. METHODS: A large international group of expert lupus clinicians was invited to participate in a 2-step process to generate, rate, and select items based on their importance in diagnosing early and established SLE, via a web-based survey. RESULTS: A total of 135 and 147 experts were invited to participate in the item-generation and item-reduction process, respectively. Of 145 items generated, item reduction resulted in 40 candidate items moving forward to the next phase. Key features for classifying both early and established SLE included characteristic autoantibodies, specific renal features, and skin manifestations. A small majority (51%) stated that 1 organ system would be sufficient for classifying SLE, but that additional typical laboratory features (antinuclear antibody, anti-double-stranded DNA) would be required. Notably, 85% of the expert group would positively classify SLE if renal pathology alone showed lupus nephritis. CONCLUSION: The Delphi exercise resulted in a set of 40 candidate criteria for the classification of SLE for subsequent assessment. This study comprised the largest panel ever involved in the development of SLE classification criteria, providing a broadly representative view of the current approach to classification of SLE.
OBJECTIVE: The American College of Rheumatology and the European League Against Rheumatism embarked on a project to reevaluate classification criteria for systemic lupus erythematosus (SLE). The first phase of the classification project involved generation of a broad set of items potentially useful for classification of SLE and their selection for use in a subsequent forced-choice decision analysis. METHODS: A large international group of expert lupus clinicians was invited to participate in a 2-step process to generate, rate, and select items based on their importance in diagnosing early and established SLE, via a web-based survey. RESULTS: A total of 135 and 147 experts were invited to participate in the item-generation and item-reduction process, respectively. Of 145 items generated, item reduction resulted in 40 candidate items moving forward to the next phase. Key features for classifying both early and established SLE included characteristic autoantibodies, specific renal features, and skin manifestations. A small majority (51%) stated that 1 organ system would be sufficient for classifying SLE, but that additional typical laboratory features (antinuclear antibody, anti-double-stranded DNA) would be required. Notably, 85% of the expert group would positively classify SLE if renal pathology alone showed lupus nephritis. CONCLUSION: The Delphi exercise resulted in a set of 40 candidate criteria for the classification of SLE for subsequent assessment. This study comprised the largest panel ever involved in the development of SLE classification criteria, providing a broadly representative view of the current approach to classification of SLE.
Authors: Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder Journal: Arthritis Rheum Date: 2012-08
Authors: Sindhu R Johnson; Raymond P Naden; Jaap Fransen; Frank van den Hoogen; Janet E Pope; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Christopher P Denton; Oliver Distler; Armando Gabrielli; Jacob M van Laar; Maureen Mayes; Virginia Steen; James R Seibold; Phillip Clements; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Lorinda Chung; Barri J Fessler; Peter A Merkel; Richard Silver; John Varga; Yannick Allanore; Ulf Mueller-Ladner; Madelon C Vonk; Ulrich A Walker; Susanna Cappelli; Dinesh Khanna Journal: J Clin Epidemiol Date: 2014-04-08 Impact factor: 6.437
Authors: Benjamin F Bruner; Joel M Guthridge; Rufei Lu; Gabriel Vidal; Jennifer A Kelly; Julie M Robertson; Diane L Kamen; Gary S Gilkeson; Barbara R Neas; Morris Reichlin; R Hal Scofield; John B Harley; Judith A James Journal: Arthritis Rheum Date: 2012-11
Authors: Sara K Tedeschi; Sindhu R Johnson; Dimitrios T Boumpas; David Daikh; Thomas Dörner; Betty Diamond; Søren Jacobsen; David Jayne; Diane L Kamen; W Joseph McCune; Marta Mosca; Rosalind Ramsey-Goldman; Guillermo Ruiz-Irastorza; Matthias Schneider; Murray Urowitz; David Wofsy; Josef S Smolen; Raymond P Naden; Martin Aringer; Karen H Costenbader Journal: Ann Rheum Dis Date: 2019-01-28 Impact factor: 19.103
Authors: Sara K Tedeschi; Sindhu R Johnson; Dimitrios Boumpas; David Daikh; Thomas Dörner; David Jayne; Diane Kamen; Kirsten Lerstrøm; Marta Mosca; Rosalind Ramsey-Goldman; Corine Sinnette; David Wofsy; Josef S Smolen; Raymond P Naden; Martin Aringer; Karen H Costenbader Journal: Arthritis Care Res (Hoboken) Date: 2018-02-22 Impact factor: 4.794
Authors: Sara K Tedeschi; Fabio Becce; Tristan Pascart; Ali Guermazi; Jean-François Budzik; Nicola Dalbeth; Georgios Filippou; Annamaria Iagnocco; Minna J Kohler; Jean-Denis Laredo; Stacy E Smith; F Joseph Simeone; Janeth Yinh; Hyon Choi; Abhishek Abhishek Journal: Arthritis Care Res (Hoboken) Date: 2022-04-19 Impact factor: 5.178
Authors: John G Hanly; Qiuju Li; Li Su; Murray B Urowitz; Caroline Gordon; Sang-Cheol Bae; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; David A Isenberg; Anisur Rahman; Joan T Merrill; Paul R Fortin; Dafna D Gladman; Ian N Bruce; Michelle Petri; Ellen M Ginzler; M A Dooley; Kristjan Steinsson; Rosalind Ramsey-Goldman; Asad A Zoma; Susan Manzi; Ola Nived; Andreas Jonsen; Munther A Khamashta; Graciela S Alarcón; Elisabet Svenungsson; Ronald F van Vollenhoven; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; Manuel Ramos-Casals; S Sam Lim; Murat Inanc; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Diane L Kamen; Anca Askanase; Chris Theriault; Vernon Farewell Journal: Arthritis Rheumatol Date: 2019-11-28 Impact factor: 10.995
Authors: Sara K Tedeschi; Tristan Pascart; Augustin Latourte; Cattleya Godsave; Burak Kundakci; Raymond P Naden; William J Taylor; Nicola Dalbeth; Tuhina Neogi; Fernando Perez-Ruiz; Ann Rosenthal; Fabio Becce; Eliseo Pascual; Mariano Andres; Thomas Bardin; Michael Doherty; Hang-Korng Ea; Georgios Filippou; John FitzGerald; Marwin Guitierrez; Annamaria Iagnocco; Tim L Jansen; Minna J Kohler; Frédéric Lioté; Mark Matza; Geraldine M McCarthy; Roberta Ramonda; Anthony M Reginato; Pascal Richette; Jasvinder A Singh; Francisca Sivera; Alexander So; Lisa K Stamp; Janeth Yinh; Chio Yokose; Robert Terkeltaub; Hyon Choi; Abhishek Abhishek Journal: Arthritis Care Res (Hoboken) Date: 2022-06-30 Impact factor: 5.178
Authors: Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson Journal: Arthritis Rheumatol Date: 2019-08-06 Impact factor: 15.483
Authors: Guillermo J Pons-Estel; Manuel Francisco Ugarte-Gil; Guillermina B Harvey; Daniel Wojdyla; Rosana Quintana; Verónica Saurit; Enrique R Soriano; Eloisa Bonfa; Loreto Massardo; Mario Cardiel; Luis M Vila; Russell Griffin; Bernardo A Pons-Estel; Graciela S Alarcón Journal: RMD Open Date: 2020-01